Over 360 antiviral and virus-related U.S. patents were granted in 1994 and described in the Antiviral Agents Bulletin. The following indexes to 1994 patents are presented below:
Assignee Index
Virus/Disease Index
Antiviral Agent Index
Vaccine Index
Immune Modulator Index
Assignee Country Index
Diagnostics Index
Recombinant DNA/RNA Index
These are followed by listings of:
Nucleoside/Nucleotide Patents
Blood Treatment Patents
Disinfectant/Sterilization Patents
Veterinary Use Patents
Index entries refer to the monthly issue of the Bulletin which presented an abstract and/or exemplary claim(s) for these patents followed by the U.S. patent number. Within the "U.S. Patents" section of each issue of the Bulletin, patents are arranged in numerical order.
**************
Assignee Index
Patent assignees are indexed below. In some cases, patents are also indexed to assignee parent companies. Patents unassigned or assigned to individuals are not represented in the Assignee Index.
__________
2920913 Canada Inc. - Dec., 5,362,442
Abbott Labs. - May, 5,308,750; June, 5,312,737; Aug., 5,330,972; Nov., 5,354,866; 5,356,772; Jan. 95, 5,374,518
Advanced Magnetics Inc. - Aug., 5,336,506
Ajinomoto Co. - Mar., 5,290,927; June, 5,310,895; July, 5,324,645; Sep., 5,336,770; 5,342,840
Akzo N.V. - Feb., 5,283,191; June, 5,316,764
Allegheny-Singer Res. Inst. - Feb., 5,279,827
Alza Corp. - Nov., 5,358,721
Ambico Inc. - Feb., 5,283,172
American Biogenetic Sciences - Apr., 5,294,548
American Biosciences Inc. - June, 5,317,009
American Cyanamid Co. - Apr., 5,296,620; June, 5,312,831
Amgen Inc. - Jan. 95, 5,372,808
Amira Inc. - July, 5,321,030; 5,324,731
Antelman Tech Ltd. - Aug., 5,336,499
Applied Biosystems Inc. - Feb., 5,281,701
Applied Immune Sciences Inc. - Feb., 5,283,034; Nov., 5,354,678
Arch Development Corp. - Mar., 5,288,641; Aug., 5,328,688; 5,334,498
Artesan Pharma GmbH - Jan. 95, 5,371,107
Asta Pharma AG - Aug., 5,334,612
Banyu Pharm. Co., Ltd. - Nov., 5,352,704
Baxter Intl. Inc. - Feb., 5,281,579; Dec., 5,360,734
Bayer AG - May, 5,300,643; Dec., 5,364,931
Baylor College of Medicine - Mar., 5,292,653
Beecham Group PLC - Nov., 5,356,886
Berlex Labs. Inc. - Jan. 95, 5,376,567
Beth Israel Hospital Assoc. - Dec., 5,366,440
Biochem Immunosystems Inc. - Apr., 5,298,596; Nov., 5,359,029
Biocontrol Technology Inc. - Nov., 5,354,277
BioMega/Boehringer Ingelheim Res. Inc. - June, 5,314,914
Biota Scientific Management Pty. - Dec., 5,360,817
Biotest AG - Nov., 5,358,845
Blue Marble Research Inc. - May, 5,308,612
Boehringer Ingelheim Intl. GmbH - May, 5,304,636; July, 5,317,089; Sep., 5,340,713
Boehringer Ingelheim Pharm. Inc. - June, 5,314,914; Dec., 5,366,972
Boehringer Mannheim GmbH - June, 5,310,876; Dec., 5,362,624; 5,369,119
Boyce Thompson Inst. for Plant Res. Inc. - May, 5,300,435
Brigham and Women's Hospital - June, 5,317,085
Bristol-Myers Squibb Co. - Mar., 5,286,649; May, 5,306,722; 5,306,837; June, 5,314,893; Aug., 5,328,835; Sep., 5,340,816; Oct., 5,344,962; Nov., 5,352,584; Dec., 5,369,098
British Technology Group Ltd. - Apr., 5,298,413; 5,298,416; May, 5,310,671; Aug., 5,332,676; Jan. 95, 5,374,558
Brown Univ. - Feb., 5,278,167
Burroughs Wellcome Co. - July, 5,318,974; 5,322,774; Jan. 95, 5,376,644
California Inst. of Biological Research - May, 5,310,729
California Inst. of Technology - Mar., 5,292,524
Cambridge Biotech Corp. - Oct., 5,352,449
Canada National Research Council - Sep., 5,338,679
Carrington Labs. Inc. - May, 5,308,838
Cell Genesys Inc. - Nov., 5,359,046
Centre National de la Recherche Scientifique - July, 5,324,513
Cetus Oncology Corp. - July, 5,324,655
Cetylite Industries Inc. - Sep., 5,338,748; 5,344,838
Chemo Sero Therapeutic Research Inst. - Mar., 5,292,506
Chiron Corp. - July, 5,324,655; Oct., 5,349,059; 5,350,671; Jan. 95, 5,371,017; 5,372,928
Ciba-Geigy AG - Nov., 5,359,044
Ciba-Geigy Corp. - July, 5,319,080; Aug., 5,332,814; 5,334,583
Cliveden Ltd. - Dec., 5,364,879
Columbia Univ. - Feb., 5,278,056; Aug., 5,334,588; Nov., 5,356,774
Commonwealth Sci. and Ind. Res. Org. - Apr., 5,298,612; Aug., 5,334,504; Oct., 5,350,575; Dec., 5,368,855
Consiglio Nazionale Delle Richerche - Apr., 5,298,391
Creighton Univ. - Nov., 5,354,674
Cryolife Inc. - Aug., 5,333,626
Cryopharm Corp. - Sep., 5,342,752
Daiichi Pharmaceutical Co. Ltd. - Mar., 5,292,506
Daikin Kogyo Co. Ltd. - Feb., 5,283,177
Dainippon Ink & Chemicals Inc. - Feb., 5,280,111
Dana Farber Cancer Inst. - Mar., 5,288,640; Apr., 5,298,407; June, 5,316,920; July, 5,321,124; Sep., 5,340,935
DEO Corp. - Dec., 5,366,739
Dev. Center for Biotechnology - Feb., 5,283,066
Duke Univ. - Nov., 5,352,576
Duphar International Research B.V. - Oct., 5,348,949
DuPont Corp. - June, 5,312,903
DuPont Merck Pharmaceutical Co. - Apr., 5,294,720
Eastman Kodak Co. - Aug., 5,334,499; Sep., 5,338,671
Eisai Co. Ltd. - June, 5,316,933
Eli Lilly & Co. (use Lilly, Eli & Co.)
Emory Univ. - Feb., 5,281,616; May, 5,304,554
Europaisches Lab. fur Molekularbiologie - Aug., 5,334,711
Farmitalia Carlo Erba SpA - Mar., 5,288,704; Jan. 95, 5,374,626
Fox Chase Cancer Center - Aug., 5,334,525; Dec., 5,360,714
Gedeon Richter Vegyeszeti Gyar Rt. - Mar., 5,292,505
Gen-Probe Inc. - Mar., 5,288,611
Genelabs Technologies, Inc. - May, 5,306,619; June, 5,312,837
Genentech Inc. - Aug., 5,336,603
Genetics Institute Inc. - Jan. 95, 5,371,193
Georgetown Univ. - Jan. 95, 5,376,542
Georgia State Univ. Found. - Feb., 5,281,616; May, 5,304,554
Godecke AG - July, 5,321,024
Great Lakes Chemical Corp. - June, 5,314,682
Greatbatch Gen Aid Ltd. - July, 5,324,643
Gristina, A.G. - Mar., 5,292,513
Hayashibara Seibutsu K.K. - Dec., 5,362,490
Health Research Inc. - Sep., 5,338,683
Henry M. Jackson Found for Adv. of Mil. Med. - Mar., 5,290,540
Hoechst AG - Feb., 5,278,152; May, 5,304,634
Hoffmann-La Roche Inc. - Feb., 5,278,286; 5,283,171; July, 5,322,770
Hydro Pharma AB - Dec., 5,369,129
Iatron Labs. - Nov., 5,354,653
Igen Inc. - July, 5,318,897
Immunex Corp. - July, 5,317,087; Nov., 5,359,039
Immuno AG - Sep., 5,340,575
Immunobiology Res. Inst. Inc. - Apr., 5,298,490
Immunomedics, Inc. - Aug., 5,332,567
Innogenetics NV - May, 5,304,466
Inst. of Org. Chem. and Biochem., Acad. of Sci. (Czech.) - May, 5,302,585; Nov., 5,352,786
Institut National de la Sante et de la Recherche Medicale - June, 5,314,808; July, 5,324,513; Sep., Reissue 34,705
Institut Pasteur - May, 5,306,614; 5,310,651; June, 5,312,902; July, 5,324,513; Sep., 5,342,930; Nov., 5,358,937; Dec., 5,364,933; Jan. 95, 5,374,519
International Paper Co. - Dec., 5,368,920
Isis Pharmaceuticals - Nov., 5,359,044; 5,359,051
Janssen Pharmaceutica NV - Mar., 5,292,738; Jan. 95, 5,371,079
Japan Tobacco Inc. - May, 5,304,731; July, 5,318,900; Sep., 5,340,732
JCR Pharmaceuticals Co. Ltd. - Feb., 5,281,577; 5,283,239; Jan. 95, 5,371,196
Jinro Ltd. - Oct., 5,348,865
Johns Hopkins Univ. - Jan. 95, 5,370,871; 5,374,520
Katakura Industry Co. - Mar., 5,288,616
Korea Green Cross Corp. - Oct., 5,346,696
Kremers-Urban Co. - June, 5,316,775; Aug., 5,334,395
Lilly, Eli & Co. - Jan. 95, 5,371,210
Liposome Co. Inc. - Aug., 5,330,689
Lonza Ltd. - Apr., 5,294,710
Lynx Therapeutics Inc. - Apr., 5,292,875
Massachusetts Inst. of Technology - Dec., 5,364,783
McMaster Univ. - Feb., 5,283,185
MCW Research Foundation Inc. - May, 5,304,113
Mediventures Inc. - Oct., 5,346,703
Medivir AB - Feb., 5,284,837
Merck & Co. Inc. - May, 5,306,635; 5,308,854; 5,310,668; Dec., 5,360,736
Merck Sharp & Dohme-Chibret - May, 5,304,559; July, 5,326,761
Merrell Dow Pharm. Inc. - Dec., 5,359,131
Michaels, E.B. Res. Assoc. Inc. - June, 5,314,917
Microbarriers Inc. - Jan. 95, 5,370,876
Miles Inc. - Apr., 5,296,604; May, 5,306,493; Jan. 95, 5,374,424
Millipore Corp. - Feb., 5,282,380
Minnesota Mining & Manufacturing Co. - Oct., 5,346,905; Nov., 5,352,784
Mitsubishi Chem. Ind. Ltd. - July, 5,318,972
Mitsui Toatsu Chemicals Inc. - Oct., 5,352,665
Mona Industries, Inc. - Mar., 5,286,719
Monsanto Co. - Oct., 5,348,886; 5,352,605
Murdock Intl. Corp. - June, 5,316,768
National Fed. of Agric. Coop. Assoc. - May, 5,302,391
National Inst. of Health of Japan - May, 5,302,507; Jan. 95, 5,372,928
National Research Development Corp. - May, 5,310,678
New York Univ - Feb., 5,278,051; June, 5,317,009; July, 5,326,788
Nippon Kayaku K.K. - Feb., 5,283,331; July, 5,324,730; Jan. 95, 5,374,625
Nippon Oil Co. Ltd. - Aug., 5,336,605
Nippon Shinyaku Co. Ltd. - Apr., 5,298,614
Nippon Zeon Co. Ltd. - Mar., 5,286,639; Dec., 5,369,025
Noda Shokukin Kogyo Co. Ltd. - Feb., 5,281,577; 5,283,239
North Carolina State Univ. - July, 5,321,140
Nova Pharmaceutical Corp. - Sep., 5,340,588
NovaGene Inc. - Mar., 5,292,653
Nycomed Dak AS - June, 5,315,016
Oklahoma Med. Res. Found. - Apr., 5,298,599
Osteotech Inc. - Apr., 5,298,222
Pharmaceutical Discovery Corp. - Oct., 5,352,461
Professional Pharmaceutical Inc. - Apr., 5,294,440
Protein Design Labs. Inc. - Oct., 5,349,053
Quadra Logic Technologies Inc. - Dec., 5,360,734
Queensland Inst. of Med. Res. - Jan. 95, 5,374,517
Rega Stichting VZW - Mar., 5,292,505; May, 5,302,585
Repla Chemical Ltd. - Feb., 5,278,184
Repligen Corp. - July, 5,321,030; 5,324,731
Research Development Foundation - June, 5,312,733; Nov., 5,354,862
Research Found. for Microbial Diseases - Apr., 5,298,394
Research Triangle Inst. - Dec., 5,364,858
Rhone-Poulenc Rorer Pharmaceuticals Inc. - May, 5,300,433
Sanwa Kagaku Kenkyusho Co. Ltd. - Sep., 5,340,806; Nov., 5,356,880
Schering Corp. - Oct., 5,350,772
SciClone Pharmaceuticals - May, 5,308,833
Sclavo SpA - Feb., 5,279,944; 5,284,937
Scripps Research Inst. - Mar., 5,288,761
Searle, G.D. & Co. - May, 5,310,745; Aug., 5,331,096 ; Sep., 5,342,951; Oct., 5,350,854
Shionogi & Co. Ltd. - July, 5,326,780
Snow Brand Milk Products Co. - Sep., 5,344,820
Stanford Univ. - June, 5,314,800; Jan. 95, 5,376,567
State of Oregon Board of Higher Educ. - Nov., 5,354,555
Sterling Winthrop Inc. - Oct., 5,349,068; Dec., 5,364,865
Stichting Rega VZW - Mar., 5,292,505; May, 5,302,585
Stichting Researchfonds Pathologie - Dec., 5,364,758
Suntory Ltd. - July, 5,324,640
Syntello AB - Feb., 5,283,320
Syntello Vaccine Development - Oct., 5,346,989
Syntex (U.S.A.) Inc. - Jan. 95, 5,376,369
T Cell Diagnostics Inc. - Mar., 5,292,636
Taito Co. Ltd. - July, 5,320,849
Tampa Bay Research Inst. - Oct., 5,346,695; 5,346,988
Teijin Ltd.; Univ. of Arizona - Apr., 5,298,419
Terumo Corp. - Jan. 95, 5,374,549
Texas A&M Univ. - Feb., 5,278,050
Time Motion Systems Co. - Dec., 5,370,534
Tulane Univ. - Sep., 5,344,774; Dec., 5,364,757
U.S. Dept. of Agriculture - Oct., 5,352,596; Dec., 5,369,025
U.S. Public Health Service - Feb., 5,283,323; Mar., 5,286,717; 5,290,677; 5,290,686; Apr., 5,296,353; June, 5,316,910; 5,317,009; Aug., 5,336,758; 5,336,764; Sep., 5,344,755; Oct., 5,348,741; Nov., 5,354,683; 5,356,795; Dec., 5,368,853; 5,376,642 ; Jan. 95, 5,374,717
Unitika Ltd. - May, 5,306,629
Univ. E Della Ricerca Sci. Tech. - Aug., 5,332,674
Univ. of Birmingham - Nov., 5,356,882
Univ. of British Columbia - Feb., 5,283,255; May, 5,308,608
Univ. of California - Feb., 5,283,255; Aug., 5,334,394; Nov., 5,359,046; Dec., 5,364,615
Univ. of California - Nov., 5,359,046
Univ. of Colorado - May, 5,306,631
Univ. of Florida - Feb., 5,286,495; Mar., 5,292,775
Univ. of Florida Res. Found. Inc. - Sep., 5,342,945; Oct., 5,352,451
Univ. of Illinois - Apr., 5,294,603
Univ. of Iowa Research Foundation - Apr., 5,294,548
Univ. of Med. and Dent. of New Jersey - July, 5,320,958
Univ. of Melbourne - Aug., 5,332,658
Univ. of Michigan - Dec., 5,360,795
Univ. of Minnesota - Apr., 5,296,353
Univ. of Nebraska - May, 5,302,517
Univ. of Pennsylvania - Sep., 5,338,829
Univ. of Rochester - Feb., 5,283,171
Univ. of Saskatchewan - Apr., 5,298,244; Jan. 95, 5,374,426
Univ. of Tennessee Res. Corp. - Feb., 5,283,185; June, 5,317,012
Univ. of Texas - Oct., 5,350,835; Dec., 5,369,101
Universidad Central de Venezuela - Oct., 5,346,811
University Patents Inc. - Feb., 5,278,302
Upjohn Co. - Feb., 5,284,764; Mar., 5,288,630; July, 5,324,664; Oct., 5,349,128; 5,352,575
Verigen Inc. - Mar., 5,286,852
Veterinary Infectious Disease Org. - Dec., 5,369,026
Virogenetics Corp. - Dec., 5,364,773
Warner-Lambert Co. - Oct., 5,350,748
Washington Univ. - Sep., 5,338,858; 5,342,922
Whitehead Inst. for Biomedical Research - Nov., 5,358,856
Wisconsin Alumni Research Foundation - Jan. 95, 5,376,549
Yale Univ. - Feb., 5,279,833
Yamasa Shoyu K.K. - May, 5,300,636
Zynaxis Inc. - Jan. 95, 5,374,531
Virus/Disease Index
Viruses and/or diseases are indexed below. Viral diseases are generally indexed by virus rather than disease name.
__________
adeno-associated virus - Nov., 5,354,678
adenovirus - July, 5,321,030; 5,314,689
adult respiratory distress syndrome - Oct., 5,352,691
Aujeszky's disease virus - Oct., 5,352,665
avian myeloblastosis virus - Sep., 5,338,680
avian RNA tumor virus - Sep., 5,338,674
avipoxviruses - Mar., 5,286,639
baculoviruses - Feb., 5,278,050; Mar., 5,288,616; 5,290,686; Apr., 5,294,548; May, 5,300,435; June, 5,316,910; July, 5,322,774; Oct., 5,348,886; 5,352,451
bovine coronavirus - Dec., 5,369,026
canarypox virus - Sep., 5,338,683
canine parvovirus - June, 5,316,764
cauliflower mosaic virus - Oct., 5,352,605
chronic fatigue syndrome - June, 5,312,817
Columbia SK virus - Jan. 95, 5,374,626
cowpox virus - Nov., 5,359,039
coxsackie virus - June, 5,314,689; Jan. 95, 5,374,626
cucumber mosaic virus - May, 5,304,731; Oct., 5,349,128
cytomegalovirus - June, 5,314,689; 5,314,800; 5,316,768; July, 5,321,030; Oct., 5,346,703; Nov., 5,358,845; Dec., 5,366,739
DNA viruses - July, 5,321,030
enterovirus - Apr., 5,298,413; 5,298,416; June, 5,314,689
entomopox virus - Sep., 5,338,679
enveloped viruses - Mar., 5,288,704; June, 5,314,917
Epstein-Barr virus - Aug., 5,334,395; Sep., 5,344,820; Jan. 95, 5,374,517; 5,374,520
equine herpesvirus type 1 - Mar., 5,292,653
feline calici virus - Jan. 95, 5,374,424
feline herpesvirus - July, 5,324,664
feline leukemia virus - May, 5,306,493; July, 5,324,643; Oct., 5,352,449; Jan. 95, 5,374,424
feline panleukopenia virus - Jan. 95, 5,374,424
feline rhinotracheitis virus - Jan. 95, 5,374,424
fowlpox virus - May, 5,310,671; Aug., 5,332,676; Sep., 5,338,683; Dec., 5,368,855; 5,369,025; Jan. 95, 5,374,558
general (broad antiviral claims) - Feb., 5,278,152; 5,278,286; 5,278,302; 5,279,827; 5,281,392; 5,281,579; 5,282,380; 5,283,034; 5,283,255; 5,283,331; 5,286,488; 5,286,495; 5,286,717; Mar., 5,286,719; 5,288,761; 5,292,513; 5,292,738; 5,292,775; Apr., 5,292,875; 5,294,603; 5,294,710; 5,294,720; 5,296,620; 5,298,222; 5,298,612; 5,298,614; May, 5,300,636; 5,300,643; 5,302,391; 5,304,113; 5,304,559; 5,306,837; 5,308,608; 5,308,626; 5,308,838; June, 5,312,831; 5,314,682; 5,314,878; 5,314,893; July, 5,318,900; 5,318,974; 5,319,080; 5,322,856; 5,324,730; 5,324,731; 5,326,567; 5,326,788; Aug., 5,332,567; 5,332,674; 5,333,626; 5,334,583; 5,334,615; 5,334,711; 5,336,499; Sep., 5,338,748; 5,338,858; 5,340,732; 5,340,816; 5,342,752; 5,344,838; Oct., 5,344,962; 5,346,905; 5,348,865; 5,348,949; 5,349,068; 5,350,772; Nov., 5,352,704; 5,352,784; 5,352,786; 5,354,855; 5,356,880; 5,356,882; 5,356,886; 5,357,636; 5,358,721; 5,359,044; 5,359,051; 5,359,131; 5,360,734; 5,360,817; 5,362,442; 5,364,865; 5,364,879; 5,366,435; 5,368,853; 5,368,920; 5,369,098; 5,369,101; 5,369,129; 5,370,534; Jan. 95, 5,370,873; 5,370,876; 5,371,196; 5,371,210; 5,372,929; 5,376,567; 5,374,424
hepadnaviruses - Aug., 5,334,525; Dec., 5,360,714
hepatitis A - Mar., 5,290,677; Apr., 5,294,548; Jan. 95, 5,372,808
hepatitis B - Feb., 5,279,944; May, 5,308,833; June, 5,314,808; 5,316,775; 5,316,936; July, 5,324,513; Aug., 5,334,588; Sep., 5,340,575; 5,344,411; Oct., 5,349,059; Dec., 5,360,714; 5,362,624; Jan. 95, 5,372,808
hepatitis C - Apr., 5,298,394; May, 5,302,507; 5,308,750; June, 5,312,737; Sep., 5,340,806; Oct., 5,350,671; Jan. 95, 5,371,017; 5,372,808; 5,372,928
hepatitis delta virus- Jan. 95, 5,372,808
hepatitis viruses - May, 5,300,433; Aug., 5,335,373; 5,336,506; 5,334,525; Oct., 5,346,696; 5,352,665; Jan. 95, 5,374,625
herpes simplex virus - Feb., 5,283,239; Mar., 5,286,649; 5,288,641; Apr., 5,292,725; 5,294,440; May, 5,306,722; June, 5,314,689; July, 5,321,030; Aug., 5,328,688; 5,331,012; Oct., 5,348,981; Nov., 5,354,653; 5,356,900; Dec., 5,360,795; 5,360,795; 5,369,129
herpesviruses - Feb., 5,281,577; June, 5,312,837; 5,314,914; July, 5,320,849; Sep., 5,338,683; Jan. 95, 5,374,517
HIV - Feb., 5,278,167; 5,278,173; 5,280,111; 5,281,616; 5,283,177; 5,284,837; Mar., 5,286,649; 5,286,852; 5,288,640; 5,290,927; 5,292,505; 5,292,636; 5,292,773; Apr., 5,296,604; 5,298,222; 5,298,391; 5,298,419; May, 5,300,433; 5,302,585; 5,304,554; 5,306,631; 5,308,612; 5,308,854; June, 5,310,876; 5,312,817; 5,312,831; 5,317,009; July, 5,321,124; 5,326,780; Aug., 5,328,835; 5,330,972; 5,331,096; 5,334,394; 5,334,498; 5,334,499; 5,335,373; 5,336,758; 5,336,764; Sep., 5,338,829; 5,342,922; 5,342,951; 5,344,755; Oct., 5,346,695; 5,346,696; 5,346,988; 5,346,989; 5,349,053; 5,350,748; 5,350,835; 5,350,854; Nov., 5,352,576; 5,352,665; 5,354,277; 5,354,683; 5,354,866; 5,356,772; 5,358,845; 5,358,937; Dec., 5,364,858; 5,366,440; 5,366,972; 5,369,119; Jan. 95, 5,370,876; 5,371,079; 5,374,424; 5,374,519; 5,374,531; 5,376,642
HIV-2 - May, 5,306,614; 5,310,651; June, 5,312,902; Dec., 5,364,933; Jan. 95, 5,374,518
HIV-3 - May, 5,304,466
HTLV-I - Oct., 5,352,665; Nov., 5,356,795; 5,359,029
HTLV-II - Feb., 5,283,320; Oct., 5,352,665; Nov., 5,359,029
human papillomavirus - Feb., 5,283,171; Apr., 5,292,725; June, 5,315,016; Aug., 5,336,605; Sep., 5,342,930; Oct., 5,346,811; Dec., 5,364,758; Jan. 95, 5,371,107; 5,376,542
immune deficiency - Apr., 5,296,353; June, 5,316,920; 5,317,012
infectious bursal disease virus - Oct., 5,350,575
infectious hematopoietic necrosis virus - Nov., 5,354,555
infectious laryngotracheitis virus - Feb., 5,279,965
influenza A - Mar., 5,290,686; Sep., 5,344,755
influenza B - Jan. 95, 5,374,717
influenza viruses - Mar., 5,286,649; 5,292,506; June, 5,316,910; July, 5,320,849; Sep., 5,344,820; Dec., 5,360,817; Jan. 95, 5,374,626
lentiviruses - May, 5,310,745
Marek's disease virus - Feb., 5,283,191; Dec., 5,369,025
Moloney murine leukemia virus - Feb., 5,278,056
Newcastle disease virus - Mar., 5,286,639; May, 5,310,678
parainfluenza virus type 3 - Feb., 5,284,764
parvovirus - May, 5,302,517
poliovirus - Mar., 5,286,640; Apr., 5,298,413; 5,298,416; June, 5,314,689; Nov., 5,358,856
pseudorabies virus - Oct., 5,352,575; 5,352,596
rabies virus - Oct., 5,348,741
reo virus - Oct., 5,352,665
respiratory syncytial virus - Mar., 5,288,630; June, 5,314,689; Jan. 95, 5,374,626
respiratory viruses - Mar., 5,290,540
retrotransposons - Nov., 5,354,674
retroviral dementia - Jan. 95, 5,376,642
retroviral particle, type a - Dec., 5,364,757
retroviruses - Feb., 5,278,167; May, 5,304,554; July, 5,318,972; 5,324,645; Aug., 5,334,612; Sep., 5,342,922; 5,342,945; Dec., 5,364,783; 5,364,931; Jan. 95, 5,371,079; 5,374,424
rhinoviruses - Feb., 5,278,184; Mar., 5,286,748; Apr., 5,298,413; 5,298,416; May, 5,304,636; Sep., 5,340,713
rotaviruses - Feb., 5,283,172; Apr., 5,292,725; 5,298,244; Aug., 5,332,658; Jan. 95, 5,374,426
rubella virus - Apr., 5,298,596
Semliki forest virus - Jan. 95, 5,374,626
Sendai virus - Mar., 5,292,524; July, 5,320,849
Sjogren's syndrome - Sep., 5,344,774
subacute sclerosing panencephalitis virus - July, 5,320,849
systemic lupus erythematosus - Dec., 5,364,757
TNF excess - May, 5,304,634
vaccinia virus - June, 5,314,689; Aug., 5,331,096; Sep., 5,338,679; 5,338,683; Oct., 5,348,741; Dec., 5,364,773; Jan. 95, 5,374,626
varicella-zoster virus - May, 5,306,635; 5,310,668; Apr., 5,292,725; June, 5,314,689; July, 5,321,030; Nov., 5,352,584; Dec., 5,360,736
visna virus - Sep., 5,342,951
Antiviral Agent Index
Substances and agents with claimed antiviral or related therapeutic activity are indexed below. Most of these are drugs or other substances which directly affect target viruses. Additional therapeutic agents can be found in the Vaccine and Immune Modulator Indexes below.
__________
1,4-diamine-2,3-dihydroxybutanes - Apr., 5,294,720
1,5-dideoxy-1,5-imino-D-glucitol deriv. - May, 5,310,745
2-formylbenzylphosphonic acid deriv. - Feb., 5,278,152
2'-alkylidenepyrimidine nucleosides - May, 5,300,636
2',3'-dideoxyadenosine - Mar., 5,290,927
4-aminoquinoline - Feb., 5,278,173
acemannan - May, 5,308,838
acridine deriv. - Sep., 5,342,752
acyclovir - Sep., 5,336,770
acyl-carnitine - June, 5,314,689
aliphatic dialdehyde- Sep., 5,344,838
alkali metal fatty acid salt - Jan. 95, 5,370,876
alpha 1-antitrypsin - Jan. 95, 5,376,633
amantadine - Mar., 5,290,686
amine oxides - June, 5,314,917
aminopyridones - May, 5,308,854
anti-inflammatory agent - Mar., 5,290,540
antigen/anti-immunoglobulin antibody conjugates - Feb., 5,283,323
antisense oligonucleotides - Feb., 5,278,051; 5,278,302; Mar., 5,286,717; Apr., 5,292,875; Nov., 5,359,044
arabinogalactan-iron complexes - Aug., 5,336,506
aromatic polycyclic diones - July, 5,326,788
ascorbic acid - Jan. 95, 5,371,107
asialoglycoprotein-drug conjugates - Oct., 5,346,696
azido-fatty acid analogs - Sep., 5,338,858
benzenes, phenoxy-methyl-phenyl-methoxy- - Oct., 5,350,772
benzimidazoles, deoxyribofuranosyl- - Dec., 5,360,795
benzodiazepin-2-(thi)ones, tetrahydroimidazo(1,4)- - Jan. 95, 5,371,079
benzothiadiazine 1-oxide, 3,4-dihydro-1-phenyl-3-thio-1,2,4- - July, 5,321,024
betaine deriv. - June, 5,314,917
bile powder - May, 5,302,391
bis-hexahydropyrimidinylalkyl deriv. - Sep., 5,342,945
BU-3889V - Mar., 5,286,649
camptothecins - July, 5,321,140; Dec., 5,364,858
carbolines, N-oxo-tetrahydro-beta- - Oct., 5,348,949
carboxamides, benzo(b)thiophene-2- - Oct., 5,350,748
catalytic antibodies - July, 5,318,897
cationic lipids - Feb., 5,283,185
CD4 - Feb., 5,278,050
chlorhexidine - Aug., 5,334,588
cholinesterase inhibitors - June, 5,312,817
cinnamic acid, p-hydroxylated deriv. - Oct., 5,346,695
crown ether polysaccharides - June, 5,314,878
cycloalkyimidazopyridin-4-amines - Nov., 5,352,784
cyclobutane deriv. - July, 5,324,730
cyclobutane nucleosides - May, 5,306,837; Oct., 5,344,962; Dec., 5,369,098
cyclobutyl oligonucleotides - Nov., 5,359,044
cyclocreatine - July, 5,321,030; 5,324,731
cyclopentyladenine, 9-(1R,2R,3S)-2,3-bis(hydroxymethyl)- - Jan. 95, 5,374,625
cyclopropane nucleosides - Sep., 5,342,840
DAP 30 and DAP 32 - June, 5,317,009
deoxynojirimycin deriv. - Aug., 5,331,096; Sep., 5,342,951; Oct., 5,350,854
detergent - Aug., 5,333,626
Dianthus caryophyllus - June, 5,317,009
diazepines, 5,11-dihydro-6H-dipyrido(3,2-b:2',3'-e)(1,4)- - Dec., 5,366,972
didemnin A deriv. - Apr., 5,294,603
diketopiperazine microparticles - Oct., 5,352,461
dinucleoside polyphosphate - May, 5,306,629
diols, pentane/hexane - Dec., 5,369,129
diphtheria toxin A - May, 5,306,631
enediyne dihydroperoxides - Mar., 5,288,761
epoxyhex-5-en-1-ol - Apr., 5,296,620
Eriobotrya japonica - Feb., 5,279,827
ethanol - Apr., 5,298,222
ethyl alcohol - Aug., 5,331,012
ethylene oxide - June, 5,314,682
ferritin - Feb., 5,283,177
fibroblast growth factor - Mar., 5,288,704
filters - Dec., 5,368,920
fluoronucleosides, 2'-deoxy-2',2'-fluorinated - Jan. 95, 5,371,210
fluorothymidine, 2',3'-dideoxy-3'- - Jan. 95, 5,376,644
galanthamine deriv. - June, 5,312,817
gamma radiation - Dec., 5,362,442
ganciclovir - Sep., 5,336,770
GAP 31 - June, 5,317,009
garlic - May, 5,302,391
gastrointestinal delivery - Nov., 5,358,721
Gelonium multiflorum - June, 5,317,009
gels, drug delivery - Oct., 5,346,703
gloves, antiseptic - Aug., 5,335,373; Nov., 5,357,636
glutaraldehyde - July, 5,322,856
glycerol, 1,2-isopropylidene- - Aug., 5,332,674
glycyrrhetinic acid deriv. - Nov., 5,356,880
guanidinoacetate - July, 5,324,731
guanidinobenzene deriv. - Nov., 5,352,704
guanine, 9(2-(phosphonomethoxy)propyl)- - May, 5,302,585
hapten-solid support complexes - Feb., 5,283,066
heat-treated hemoglobin - Feb., 5,281,579
heptafluoropropane - June, 5,314,682
herpes simplex virus UL13 - Aug., 5,334,498
histidine, L- - Oct., 5,352,691
HIV art (rev) protein - July, 5,321,124
HIV peptides - Oct., 5,346,989
homocyclocreatine - July, 5,324,731
hydrocarbon peroxide deriv. - Dec., 5,364,879
hyperthermia, whole body - Nov., 5,354,277
imexon - Dec., 5,369,119
imidazole deriv. - July, 5,326,780
imidazole-4-ethanamine, phosphate - Apr., 5,294,440
influenza A M2 protein - Mar., 5,290,686
inosine, 2',3'-dideoxy (ddI) - Jan. 95, 5,376,642
interleukin-2/antibody fusion proteins - Oct., 5,349,053
iodinated resin - Dec., 5,370,534
iodine, controlled-release - Sep., 5,344,411
kappa-casein - Sep., 5,344,820
KU 10,001 - June, 5,316,775; Aug., 5,334,395
kukui nut - Feb., 5,286,488
Lentinus edodes - Feb., 5,283,239
leukoregulin - Dec., 5,368,853
licorice - May, 5,302,391
lidocaine - Mar., 5,290,686
lipoproteins, oxidized - Dec., 5,366,440
liposomal adjuvants - June, 5,312,620
liposomes - Feb., 5,279,833; Aug., 5,330,689; Sep., 5,340,588
liver extracts - June, 5,316,775; Aug., 5,334,395
magnetic fields - Dec., 5,366,435
MCA 86 monoclonal antibody - Apr., 5,298,419
methionine deriv. - Mar., 5,292,773
microcapsules - Feb., 5,286,495
Mirabilis antiviral protein - July, 5,318,900; Sep., 5,340,732
muramyldipeptide deriv. - Mar., 5,292,506; Jan. 95, 5,376,369
N-acetylmuramyl-L-alanyl-D-isoglutaminyl-L-alanine-2-(1,2-dipalmitoyl-sn-glycero3-hydroxyphosphoryloxy)-ethylamide - Aug., 5,334,583
naltrexone - Nov., 5,356,900
naphthoquinone deriv. - June, 5,314,914
neem extracts - Jan. 95, 5,370,873
neuraminic acid, 2-deoxy-2,3-didehydro-N-acetyl deriv. - Dec., 5,360,817
nonapeptide - Oct., 5,352,665
nucleoside deriv. - June, 5,310,895
nucleosides, 2'-fluoro- - Aug., 5,336,764
nucleosides, 5'-alkylphosphonyl- - Jan. 95, 5,374,626
nucleosides, acyclic side chain - July, 5,318,974
nucleosides, acyclic - Sep., 5,336,770
nucleosides, glycosylphospholipid - Nov., 5,358,937
nucleosides, hydroxymethyl(methylenecyclopentyl)- - Sep., 5,340,816
oligonucleotides - July, 5,319,080
opiate receptor antagonists - Nov., 5,356,900
oxetanocin, 2-halogeno- - Feb., 5,283,331
oxidizing agents - Feb., 5,281,392
oxygen radical scavenger - Feb., 5,283,034
oxygermylpropionic acid polymers - Sep., 5,340,806
parabactin - Mar., 5,292,775
pendulan - July, 5,320,849
pentamidine - Dec., 5,364,615
peptides - Apr., 5,298,490
phagocytosable particles - Mar., 5,292,513
phenoxyalkylisoazoles, 1,2,4-oxadiazolyl- - Oct., 5,349,068
phospholipids - Mar., 5,286,719
photodynamic agents - May, 5,304,113; Dec., 5,360,734
photosensitizers - Sep., 5,342,752; Dec., 5,369,101
Phytolacca insularis antiviral protein - Oct., 5,348,865
piperidines, phenoxy- deriv. - Dec., 5,364,865
podophyllotoxin - June, 5,315,016; Aug., 5,336,605
poly I:poly(cytidylate/4-thiouridylate) - Apr., 5,298,614
polystyrenesulfonate - May, 5,308,612
POP-POE block polymers - Jan. 95, 5,376,369
porphyrin deriv. - Feb., 5,281,616; 5,283,255; May, 5,308,608; Dec., 5,369,101
potassium nitrate - Oct., 5,348,981
pseudopeptides, phosphonate-containing - Dec., 5,364,931
purine deriv. - Aug., 5,332,814; Nov., 5,356,886
pyridazinamines - Mar., 5,292,738
pyrimidine nucleosides - July, 5,318,972
pyrimidine, 1-carboxymethyl-2-iminohexahydro- - July, 5,324,731
pyrimidines, 6-pyridyl - Feb., 5,278,167
pyrimidines, N-5-protected 2,5-diamino-4,6-dichloro- - Apr., 5,294,710
pyrimidinones/pyrimidinediones - June, 5,314,893
pyrroles/pyrrolidines - Feb., 5,278,184
quaternary ammonium compounds - Sep., 5,338,748; 5,344,838
quillaja - May, 5,302,391
quinolin-4-amines, 1H-imidazo(4,5-c)- - Oct., 5,346,905
quinolines,4-((alkyl or dialkyl)amino)- - May, 5,304,554
quinolone metal complexes - May, 5,304,559
quinolone-carboxylic acids - May, 5,300,643
reverse transcriptase inhibitors - Sep., 5,344,774
ribonucleoside phosphoramidites - Feb., 5,281,701
ribozymes - Apr., 5,298,612; Aug., 5,334,711; Nov., 5,354,855; 5,359,051
rubella virus E1 and C proteins - Apr., 5,298,596
Salphurbon Lotion - Oct., 5,348,981
schizophyllan - July, 5,320,849
scleroglucan - July, 5,320,849
silver acyclic polyether polymers - July, 5,326,567
silver sulfadiazine - Aug., 5,334,588
sodium deoxycholate - Aug., 5,334,588
sodium thiocyanate - May, 5,300,433
soy protein hydrolysate - Aug., 5,330,972
stilbenes, sulfonic acid deriv. - Dec., 5,359,131
sulfated polysaccharides - Mar., 5,288,704
sulfonic acid deriv. - June, 5,312,837
sulfur - Oct., 5,348,981
sulphated polyvinyls - Mar., 5,292,505
sulphur carboxylic acid deriv. - Aug., 5,334,612
surfactants - Jan. 95, 5,371,196
T-cell proteins - Oct., 5,346,988
tetra-polyols - Jan. 95, 5,376,369
tetrasilver tetroxide - Aug., 5,336,499
texaphyrin - Dec., 5,369,101
thionucleosides, pyrimidine 4'- - Nov., 5,356,882
thymidine derivatives - May, 5,306,722
thymosin alpha 1 - May, 5,308,833
tocopheryl oligosaccharides - Feb., 5,280,111
toluenesulfonyloxypropane, (RS)-1-fluoro-2-phosphonomethoxy-3-p- - Nov., 5,352,786
tri-n-butyl phosphate - Jan. 95, 5,371,196
trimethylenebis(1,3-dioxolane) - Aug., 5,334,615
tripyrrole dimethine deriv. - Dec., 5,369,101
TRP-185 cellular protein - Oct., 5,350,835
uracil, (E)-5-(2-bromovinyl)arabinofuranosyl- - Nov., 5,352,584
ureas - June, 5,312,831
urethanes - June, 5,312,831
vectors - Dec., 5,364,773
Vaccine Index
Viral vaccines and vaccine vectors are indexed below.
__________
antibody conjugates - Aug., 5,332,567
antigen/anti-immunoglobulin antibody conjugates - Feb., 5,283,323
avian RNA tumor virus, PrASV - Sep., 5,338,674
avipoxviruses - Mar., 5,286,639
bovine coronavirus - Dec., 5,369,026
canarypox virus - Sep., 5,338,683
canine parvovirus - June, 5,316,764
cationic lipids - Feb., 5,283,185
cytomegalovirus - June, 5,314,800
enterovirus - Apr., 5,298,413; 5,298,416
entomopox virus - Sep., 5,338,679
Epstein-Barr virus - Jan. 95, 5,374,517
equine herpesvirus type 1 - Mar., 5,292,653
feline calici virus - Jan. 95, 5,374,424
feline herpesvirus - July, 5,324,664
feline leukemia virus - May, 5,306,493; Oct., 5,352,449; Jan. 95, 5,374,424
feline panleukopenia virus - Jan. 95, 5,374,424
feline rhinotracheitis virus - Jan. 95, 5,374,424
fowlpox virus - Aug., 5,332,676; Sep., 5,338,683; Dec., 5,368,855; 5,369,025; Jan. 95, 5,374,558
hapten-solid support complexes - Feb., 5,283,066
hepatitis A virus - Apr., 5,294,548
hepatitis B virus - June, 5,314,808; July, 5,324,513; Sep., 5,340,575; Oct., 5,349,059
hepatitis C virus - Apr., 5,298,394; June, 5,312,737; 5,372,928
herpes simplex virus - Mar., 5,288,641; Aug., 5,328,688
herpes simplex virus vectors - Mar., 5,288,641
herpesviruses - Sep., 5,338,683; Jan. 95, 5,374,517
HIV - Mar., 5,286,852; 5,292,636; June, 5,310,876; Aug., 5,328,835; 5,334,394; 5,336,758; Sep., 5,338,829; Oct., 5,346,989
HIV-2 - May, 5,306,614; June, 5,312,902; Dec., 5,364,93
HIV-3 - May, 5,304,466
HTLV-2 - Feb., 5,283,320
human papillomavirus - Sep., 5,342,930
infectious bursal disease virus - Oct., 5,350,575
infectious hematopoietic necrosis virus - Nov., 5,354,555
infectious laryngotracheitis virus - Feb., 5,279,965
influenza A - Mar., 5,290,686
influenza B - Jan. 95, 5,374,717
influenza - Mar., 5,292,506; June, 5,316,910
liposomal adjuvants - June, 5,312,620; Sep., 5,340,588
liposomes - Mar., 5,292,524
Marek's disease virus - Feb., 5,283,191; Dec., 5,369,025
microcapsules - Feb., 5,286,495
muramyldipeptide adjuvants - Jan. 95, 5,376,369
Newcastle disease virus - Mar., 5,286,639
parainfluenza virus type 3 - Feb., 5,284,764
parvovirus - May, 5,302,517
piperidines, phenoxy- deriv. - Dec., 5,364,865
platelet encapsulation - Mar., 5,292,524
poliovirus - Mar., 5,286,640; Apr., 5,298,413; 5,298,416
pseudorabies virus - Oct., 5,352,575; 5,352,596
rabies virus - Oct., 5,348,741
respiratory syncytial virus - Mar., 5,288,630
retroviral particle, type a - Dec., 5,364,757
retroviruses - July, 5,324,645
reverse transcriptase inhibitors - Sep., 5,344,774
rhinovirus - Apr., 5,298,413; 5,298,416; May, 5,304,636
rhinovirus receptors - May, 5,304,636
rotavirus - Apr., 5,298,244; 5,332,658; Jan. 95, 5,374,426
rubella virus - Apr., 5,298,596
Sendai virus - Mar., 5,292,524
Sjogren's syndrome - Sep., 5,344,774
systemic lupus erythematosus - Dec., 5,364,757
T-cell differentiation antigens - Mar., 5,292,636
T-cell receptor proteins - Apr., 5,296,353
TIA-1 monoclonal antibody - Apr., 5,298,407
vaccinia virus - Sep., 5,338,679; 5,338,683; Oct., 5,348,741; Dec., 5,364,773
varicella-zoster virus - May, 5,306,635; 5,310,668; Dec., 5,360,736
vectors - Dec., 5,364,773
virosome vaccines - Mar., 5,292,506
Immune Modulator Index
Immune modulators, stimulants and vaccine adjuvants are indexed below.
__________
acemannan - May, 5,308,838
antigen/anti-immunoglobulin antibody conjugates - Feb., 5,283,323
B-cell CR2 receptors - May, 5,310,729
B-cell differentiation factor - July, 5,324,640
benzothiadiazine 1-oxide, 3,4-dihydro-1-phenyl-3-thio-1,2,4- - July, 5,321,024
bile powder - May, 5,302,391
gamma signal peptide - July, 5,324,655
garlic - May, 5,302,391
human growth hormone - June, 5,317,012
imexon - Dec., 5,369,119
immunoadheson - Aug., 5,336,603
interferon - July, 5,324,655; Jan. 95, 5,376,567
interferon, gamma- - Feb., 5,284,937; May, 5,308,626
interferon, leukocyte - Jan. 95, 5,372,808
interferon, unglycosylated - Feb., 5,278,286
interferon-gamma - Dec., 5,362,490
interferon-omega - July, 5,317,089
interleukin-11 - Jan. 95, 5,371,193
interleukin-2 receptors - July, 5,317,087
interleukin-2 - May, 5,308,626; June, 5,312,903; Jan. 95, 5,374,549
interleukin-2/antibody fusion proteins - Oct., 5,349,053
interleukin-4 - Jan. 95, 5,374,549
licorice - May, 5,302,391
liposomal adjuvants - Mar., 5,292,524; June, 5,312,620
lymphocyte activation antigen HB15 - June, 5,316,920
microcapsules - Feb., 5,286,495
muramyldipeptide deriv. - Mar., 5,292,506; Jan. 95, 5,376,369
NK cell activating factor - June, 5,316,933
peptides - Apr., 5,298,490
phagocytosable particles - Mar., 5,292,513
platelet encapsulation - Mar., 5,292,524
poly I:poly(cytidylate/4-thiouridylate) - Apr., 5,298,614
POP-POE block polymers - Jan. 95, 5,376,369
proteoglycan - June, 5,317,085
quillaja - May, 5,302,391
quinolin-4-amines, 1H-imidazo(4,5-c)- - Oct., 5,346,905
soy protein hydrolysate - Aug., 5,330,972
T-cell proteins - June, 5,312,733
tetra-polyols - Jan. 95, 5,376,369
thymosin alpha 1 - May, 5,308,833
TIA-1 monoclonal antibody - Apr., 5,298,407
tissue factor, recombinant - Apr., 5,298,599
tumor necrosis factor antagonists - May, 5,304,634; Nov., 5,359,039
tumor necrosis factor - July, 5,324,655
ureas and urethanes - June, 5,312,831
virosome vaccines - Mar., 5,292,506
Assignee Country Index
Patents are indexed below by the countries where their assignees are located. Note, patents solely assigned to U.S. organizations (240 or 66%) are not listed.
__________
Australia - Apr., 5,298,612; Aug., 5,332,658; 5,334,504; Oct., 5,350,575; Dec., 5,360,817; 5,368,855; Jan. 95, 5,374,517
Austria - Sep., 5,340,575
Canada - Apr., 5,298,244; 5,298,596; May, 5,308,608; June, 5,314,914; Sep., 5,338,679; Nov., 5,359,029; Dec., 5,362,442; 5,369,026; Jan. 95, 5,374,426
Canada and U.S. - Feb., 5,283,185; 5,283,255; Dec., 5,360,734
Czechoslovakia - May, 5,302,585; Nov., 5,352,786
Belgium - May, 5,292,505; 5,302,585
Denmark - June, 5,315,016
France - May, 5,304,559; 5,306,614; 5,310,651; June, 5,312,902; 5,314,808; July, 5,324,513; 5,326,761; Sep., 5,342,930; Nov., 5,358,937; Dec., 5,364,933; Jan. 95, 5,374,519
Germany - Feb., 5,278,152; May, 5,300,643; 5,304,634; 5,304,636; June, 5,310,876; July, 5,317,089; 5,321,024; Aug., 5,334,612; 5,334,711; Nov., 5,358,845; Dec., 5,362,624; 5,364,931; 5,369,119; Jan. 95, 5,371,107
Germany and U.S. - Nov., 5,359,044
Hungary - Mar., 5,292,505
Italy - Feb., 5,278,184; 5,279,944; 5,284,937; Mar., 5,288,704; Apr., 5,298,391; Aug., 5,332,674; Jan. 95, 5,374,626
Japan - Feb., 5,280,111; 5,281,577; 5,283,177; 5,283,239; 5,283,331; Mar., 5,286,639; 5,288,616; 5,290,927; 5,292,506; Apr., 5,298,394; 5,298,614; May, 5,300,636; 5,302,391; 5,302,507; 5,304,731; 5,306,629; June, 5,310,895; 5,316,933; July, 5,318,900; 5,318,972; 5,320,849; 5,324,640; 5,324,645; 5,324,730; 5,326,780; Aug., 5,336,605; Sep., 5,336,770; 5,340,732; 5,340,806; 5,342,840; 5,344,820; Oct., 5,352,665; Nov., 5,352,704; 5,354,653; 5,356,880; Dec., 5,362,490; Jan. 95, 5,371,196; 5,374,549; 5,374,625
Japan and U.S. - Apr., 5,298,419; Dec., 5,369,025; Jan. 95, 5,372,928
Korea - Oct., 5,346,696; 5,348,865
Netherlands - Feb., 5,283,191; Mar., 5,292,738; May, 5,304,466; June, 5,316,764; Oct., 5,348,949; Dec., 5,364,758; Jan. 95, 5,371,079
Sweden - Feb., 5,283,320; 5,284,837; Oct., 5,346,989; Dec., 5,369,129
Switzerland - Apr., 5,294,710
Taiwan - Feb., 5,283,066
U.K. - Apr., 5,298,413; 5,298,416; May, 5,310,671; 5,310,678; Aug., 5,332,676; Nov., 5,356,886; Dec., 5,364,879; Jan. 95, 5,374,558
U.S.A. - all other patents (240) are assigned to U.S. organizations
Venezuela - Oct., 5,346,811
Diagnostics Index
Diagnostics and assays are generally indexed by viral targets, reagents or diseases.
__________
cytomegalovirus - June, 5,314,800; Nov., 5,358,845
Epstein-Barr virus - Jan. 95, 5,374,517; 5,374,520
general - Aug., 5,332,567; Jan. 95, 5,372,929
hepatitis A - Mar., 5,290,677
hepatitis B - Feb., 5,279,944; June, 5,316,936; Dec., 5,362,624
hepatitis C - Apr., 5,298,394; May, 5,302,507; 5,308,750; Oct., 5,350,671; Jan. 95, 5,372,928
herpes simplex virus - Nov., 5,354,653
herpesviruses - Jan. 95, 5,374,517
HIV - Feb., 5,283,177; Mar., 5,286,852; 5,288,640; 5,292,636; Apr., 5,298,391; Aug., 5,334,499; Sep., 5,338,829; 5,344,755; Nov., 5,352,576; 5,356,772; 5,358,845; Jan. 95, 5,374,519; 5,374,531
HIV-2 - May, 5,306,614; 5,310,651; June, 5,312,902; Dec., 5,364,933; Jan. 95, 5,374,518
HIV-3 - May, 5,304,466
HPV - Feb., 5,283,171; Oct., 5,346,811; Dec., 5,364,758
HTLV-I - Nov., 5,356,795; 5,358,845
HTLV-II - Nov., 5,359,029
influenza A - Sep., 5,344,755
influenza B - Jan. 95, 5,374,717
pseudorabies virus - Oct., 5,352,575; 5,352,596
retroviral particle, type a - Dec., 5,364,757
rhinoviruses - Sep., 5,340,713
rotavirus, type C - Feb., 5,283,172
Sjogren's syndrome - Sep., 5,344,774
systemic lupus erythematosus - Dec., 5,364,757
Recombinant DNA/RNA Index
Patents involving recombinant DNA/RNA technologies are indexed below by virus. Entries generally refer to recombinant antigens and viral vectors.
__________
adeno-associated virus - Nov., 5,354,678
avipoxvirus - Mar., 5,286,639
baculoviruses - Mar., 5,288,616; Apr., 5,294,548; May, 5,300,435; July, 5,322,774; Oct., 5,348,886; 5,352,451
bovine coronavirus - Dec., 5,369,026
canarypox virus - Sep., 5,338,683
cauliflower mosaic virus - Oct., 5,352,605
cucumber mosaic virus - May, 5,304,731; Oct., 5,349,128
enterovirus - Apr., 5,298,413
Epstein-Barr virus - Jan. 95, 5,374,517; 5,374,520
equine herpesvirus type 1 - Mar., 5,292,653
feline herpesvirus - July, 5,324,664
fowlpox virus - May, 5,310,671; Aug., 5,332,676; Sep., 5,338,683; Dec., 5,368,855; 5,369,025; Jan. 95, 5,374,558
hepadnaviruses - Aug., 5,334,525; Dec., 5,360,714
hepatitis A virus - Apr., 5,294,548
hepatitis B virus - June, 5,314,808; Sep., 5,340,575; Oct., 5,349,059; Dec., 5,360,714; 5,362,624
hepatitis C virus - May, 5,302,507; June, 5,312,737; Oct., 5,350,671; Jan. 95, 5,371,017; 5,372,928
hepatitis viruses - Aug., 5,334,525
herpes simplex virus - Aug., 5,328,688
herpesviruses - Sep., 5,338,683; Jan. 95, 5,374,517
HIV - Mar., 5,288,640; June, 5,310,876; Aug., 5,328,835; Nov., 5,356,772; Jan. 95, 5,374,519
HIV-2 - May, 5,306,614; Nov., 5,354,683; Dec., 5,364,933
HTLV-I - Nov., 5,359,029
HTLV-II - Nov., 5,359,029
human papillomavirus - Sep., 5,342,930; Jan. 95, 5,376,542
infectious bursal disease virus - Oct., 5,350,575
infectious hematopoietic necrosis virus - Nov., 5,354,555
influenza B - Jan. 95, 5,374,717
Marek's disease virus - Feb., 5,283,191; Dec., 5,369,025
Moloney murine leukemia virus - Feb., 5,278,056; 5,279,965
Newcastle disease virus - Mar., 5,286,639; May, 5,310,678
parainfluenza virus type 3 - Feb., 5,284,764
parvovirus - May, 5,302,517
phage vector - Jan. 95, 5,376,549
poliovirus - Apr., 5,298,413
pseudorabies virus - Oct., 5,352,575; 5,352,596
retroviruses - July, 5,324,645; Dec., 5,364,783
rhinovirus - Apr., 5,298,413
rotavirus - Jan. 95, 5,374,426
TIA-1 monoclonal antibody - Sep., 5,340,935
vaccinia virus - Sep., 5,338,68
varicella-zoster virus - May, 5,306,635; 5,310,668
Nucleoside/Nucleotide Patents
Patents involving nucleosides, nucleotides and related technologies are listed below.
__________
Feb., 5,278,051; 5,278,302; 5,281,701; Mar., 5,286,717; 5,288,611; 5,290,677; Apr., 5,292,875; 5,298,614; May, 5,306,614; 5,306,629; 5,306,837; 5,310,651; June, 5,310,895; 5,317,085; July, 5,318,972; 5,319,080; 5,324,643; Aug., 5,332,814; 5,334,499; 5,334,711; Sep., 5,336,770; 5,338,671; 5,340,713; 5,340,816; 5,342,840; Oct., 5,346,811; Nov., 5,356,774; 5,359,044; 5,359,051; Dec., 5,360,795; 5,364,758; Jan. 95, 5,372,929; 5,374,625; 5,374,626; 5,376,642
Blood Treatment Patents
Patents involving antiviral treatments or processing of blood or blood products are listed below.
__________
Feb., 5,281,392; 5,281,579; 5,281,616; 5,283,255; May, 5,300,433; 5,304,113; June, 5,314,878; July, 5,326,788; Sep., 5,340,713; 5,342,752; Dec., 5,360,734; 5,362,442; 5,369,101; Jan. 95, 5,371,196; 5,376,633
Disinfectant/Sterilization Patents
Patents involving disinfection, sterilization and related technologies are listed below.
__________
Feb., 5,281,392; 5,281,579; 5,281,616; 5,282,380; 5,283,034; 5,283,255; Mar., 5,286,719; Apr., 5,298,222; May, 5,300,433; 5,304,113; June, 5,314,878; 5,314,917; July, 5,322,856; 5,326,788; Aug., 5,333,626; Sep., 5,338,748; 5,342,752; 5,344,838; Dec., 5,362,442; 5,369,101; Jan. 95, 5,371,196; 5,376,633
Veterinary Use Patents
Patents involving veterinary applications are listed below.
__________
Feb., 5,279,965; Mar., 5,286,639; 5,292,653; May, 5,302,391; June, 5,316,764; July, 5,324,664; Sep., 5,338,674; 5,338,679; Oct., 5,348,741; 5,350,575; Nov., 5,354,555; 5,359,039; Dec., 5,368,855; 5,369,025; 5,369,026; Jan. 95, 5,374,558